UCB: H1 Beat on legacy assets; FY26 guide raised

Research evidence excerpt

UCB: H1 Beat on legacy assets; FY26 guide raised

Marjan Daeipour - Specialist Sales - European Healthcare AC (44 20) 7134-1329 Europe Specialist Sales J P M O R G A Nmarjan.daeipour@jpmorgan.com

J.P. Morgan Securities plc 30 July 2026

Comment/feedback welcome.

Regards,

Marjan

J.P. Morgan Healthcare Contacts

Marjan Daeipour (EU, Global Sector Head) marjan.daeipour@jpmorgan.com +44 207 134 1329

Elif Korkmaz (US) elif.korkmaz@jpmorgan.com +1 212 622 2949

Healthcare Trading:

Mark O’Sullivan (EU) mark.osullivan@jpmorgan.com+44 207 134 0542

Jacqueline Bukzin jacqueline.bukzin@jpmchase.com

US Derivatives: Leon Aboudi leon.aboudi@jpmorgan.com+1 646 408 7356

Pharma Research:

Richard Vosser richard.vosser@jpmorgan.com+44 207 742 6652

Chris Schott (US) Christopher.schott@jpmorgan.com+1212 622 5676

Seiji Wakao (JPN) seiji.wakao@jpmorgan.com +81 367 36 8612

Jihyun Cho (Korea) jihyun.cho@jpmorgan.com+82 2 779 0554

Zain Ebrahim (EU) zain.ebrahim@jpmorgan.com+44 020 34931163

Sophia Graeff Buhl Nielsen (EU) sophia.graeffbuhlnielsen@jpmorgan.com +44 020 77423918

Biotechnology Research:

Jessica Fye (US) Jessica.m.fye@jpmorgan.com+1 212 622 4165

Anupam Rama (US) anupam.rama@jpmorgan.com+1 212 622 0900

Tessa Romero (US) Tessa.T.Romero@jpmorgan.com +1 212 622 4484

Brian Cheng brian.cheng@jpmorgan.com +1 212 622 0449

MedTech Research:

David Adlington (EU) david.adlington@jpmorgan.com+44 207 134 5828

Robbie Marcus (US) robert.j.marcus@jpmorgan.com+1 212 622 6657

Life Science Tool & Diagnostics:

Casey Woodring Casey.Woodring@jpmchase.com+1 212 622 9074

Managed Care, Facilities, Distribution, Technology & PBMs:

Lisa Gill lisa.c.gill@jpmorgan.com+1 212 622 6466

John Stansel John.Stansel@jpmorgan.com+1212 622 0083

Benjamin Rossi Benjamin.Rossi@jpmorgan.com+1 212 622 9603